13.07.2015 Views

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

15. Wallace WH, Blacklay A, Eiser C et al Developingstrategies <strong>for</strong> long term follow up <strong>of</strong> survivors <strong>of</strong>childhood cancer. Bmj. 2001;323:271-4.Selected Abstracts:1) Extended follow-up <strong>of</strong> long-term survivors <strong>of</strong>childhood acute lymphoblastic leukemia.Pui CH, Cheng C, Leung W, et al. N Engl J Med.2003;349:640-9Backgraound: Children who survive acute lymphoblasticleukemia are at risk <strong>for</strong> leukemia-related or treatment-relatedcomplications, which can adversely affect survival andsocioeconomic status. We determined the long-term survivaland the rates <strong>of</strong> health insurance coverage, marriage, andemployment among patients who had attained at least 10 years<strong>of</strong> event-free survival. METHODS: A total <strong>of</strong> 856 eligiblepatients were treated between 1962 and 1992 in 13 consecutiveclinical trials. Survival rates, the cumulative risk <strong>of</strong> a secondneoplasm, and selected indicators <strong>of</strong> socioeconomic statuswere analyzed <strong>for</strong> the entire group and <strong>for</strong> patients who did ordid not receive cranial or craniospinal radiation therapy duringinitial treatment. RESULTS: Fifty-six patients had majoradverse events, including 8 deaths during remission, 4 relapses,and 44 second neoplasms (41 <strong>of</strong> them radiation-related); most<strong>of</strong> the second neoplasms were benign or <strong>of</strong> a low grade <strong>of</strong>malignant potential. The risk <strong>of</strong> a second neoplasm wassignificantly higher in the 597 patients who received radiationtherapy (irradiated group) than in the 259 patients who didnot receive radiation therapy (nonirradiated group) (P=0.04;estimated cumulative risk [+/-SE] at 20 years, 20.9+/-3.9percent vs. 0.95+/-0.9 percent). The death rate <strong>for</strong> the irradiatedgroup slightly exceeded the expected rate in the general U.S.population (standardized mortality ratio, 1.90; 95 percentconfidence interval, 1.12 to 3.00), whereas that <strong>for</strong> the414

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!